wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q44778300-29FF63DA-F5DE-41B8-A5AE-E6F12A7F64F5
Q44778300-29FF63DA-F5DE-41B8-A5AE-E6F12A7F64F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-29FF63DA-F5DE-41B8-A5AE-E6F12A7F64F5
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.
P2860
Q44778300-29FF63DA-F5DE-41B8-A5AE-E6F12A7F64F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44778300-29FF63DA-F5DE-41B8-A5AE-E6F12A7F64F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da93738df30da014798f15936346ab13b32d57f0
P2860
Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study.